Molecular & Cellular Characterisation of Oral Lichen Planus

April 17, 2024 updated by: University of Birmingham
The principal research objective is to provide enhanced understanding of the cellular and molecular events important in the pathogenesis of Oral Lichen Planus to enable improved diagnosis and development of novel treatments for patients.

Study Overview

Status

Completed

Conditions

Detailed Description

The following questions will also be addressed:

  1. Are the histological architectural tissue changes that take place in oral lichen planus quantifiable using computer based imaging, graph theory and fractal geometry principles? Quantification of these changes would allow the development of a tool to facilitate the accurate measurement of response to treatment.
  2. What is the nature of such architectural changes and what are the differences with normal, dysplastic and neoplastic epithelia (the investigators have morphometrical data collected from previous research to allow such comparisons).
  3. Is it possible to produce evidence-based statistical classification into established diagnostic classes using the proposed methodology? This would contribute towards making histopathological diagnosis more quantitative, reproducible and accurate.
  4. Is it possible to automate such morphometrical analysis/classification? This would allow large data sets to be screened automatically in a shorter time frame and at lower cost than human based screening.
  5. Is it possible to determine differences in genetics and gene expression of keratinocytes involved in Oral Lichen Planus compared to those of 'normal' tissue by using biopsy material and an in vitro model of oral lichen planus?

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ana Poveda Gallego, Consultant
  • Phone Number: +44 0121 466 6670
  • Email: p.g.ana@bham.ac.uk

Study Locations

    • West Midlands
      • Birmingham, West Midlands, United Kingdom, B5 7EG
        • Birmingham Dental Hospital and School of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients registered at Birmingham Dental Hospital and attending a clinic for OLP diagnosis.

Patients will be identified by their normal healthcare consultant and invited to participate.

Informed consent will always be obtained prior to any study related procedures being undertaken.

Description

Inclusion Criteria:

  1. Patient is 16 years old or over
  2. Patient is willing and able to provide valid informed consent
  3. Patient is attending the Oral Lichen Planus clinic and will be having a routine clinical biopsy taken

Exclusion Criteria:

  1. Patient under 16 years old
  2. Patient is immunocompromised
  3. Patients with comorbid disease state e.g. other inflammatory disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histological architecture
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
Are the histological architectural tissue changes that take place in oral lichen planus quantifiable using computer based imaging, graph theory and fractal geometry principles?
Through study completion, (maximum 12 months from the defined end of study)
Comparisons with other dysplastic lesions
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
What is the nature of such architectural changes and what are the differences with normal, dysplastic and neoplastic epithelia
Through study completion, (maximum 12 months from the defined end of study)
Statistical classifications
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
Is it possible to produce evidence-based statistical classification into established diagnostic classes using the proposed methodology
Through study completion, (maximum 12 months from the defined end of study)
Automation of morphological features
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
Is it possible to automate such morphometrical analysis/classification?
Through study completion, (maximum 12 months from the defined end of study)
Molecular expression of Oral Lichen Planus markers
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
Is it possible to determine differences in genetics and gene expression of keratinocytes involved in Oral Lichen Planus compared to those of 'normal' tissue by using biopsy material and an in vitro model of oral lichen planus?
Through study completion, (maximum 12 months from the defined end of study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gabriel Landini, Phd, University of Birmingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 26, 2016

Primary Completion (Actual)

February 26, 2023

Study Completion (Actual)

February 26, 2023

Study Registration Dates

First Submitted

January 31, 2020

First Submitted That Met QC Criteria

February 27, 2020

First Posted (Actual)

February 28, 2020

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 17, 2024

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oral Lichen Planus

3
Subscribe